A B S T R A C T Urinary inorganic phosphate excretion was studied before and during the administration of sodium bicarbonate and acetazolamide in dogs that were not given infusions of phosphate. The excretion fraction of filtered phosphate increased after sodium bicarbonate or acetazolamide was given. This phosphaturia was attributed to decreased tubular reabsorption of phosphate consequent to alkalinization of either tubular urine or cells.
INTRODUCTION
The role of the kidney in phosphate homeostasis is still imperfectly understood. There is particular disagreement about whether acute changes of systemic or urinary pH affect the urinary excretion of orthophosphate (P, [1, 2] ). Previous studies that were directed toward answering this question usually entailed the infusion of P in order to estimate its reabsorptive transport maximum (Tmp). However, phosphate infusion indirectly causes increased parathormone secretion (3) that can, in turn, decrease the tubular reabsorption of P. Accordingly, it would be preferable to evaluate the influence of other variables in the absence of acute loading with exogenous P.
The effect of urinary pH changes on P excretion was therefore examined in clearance experiments with fasting anesthetized dogs not given P.
The fraction of filtered-P that was excreted increased during urinary alkalinization regardless of whether the pH of the blood increased (NaHCO8 infusion) or decreased (acetazolamide administration).
METHODS
Subjects and experimental procedures. The experiments were performed in 29 mongrel female dogs, weighing between 12 and 19 kg, that had been fasted and thirsted for 18 hr before being anesthetized with i.v. pentobarbital, 30 mg/kg. 200-300 ml of 154 mM NaCl was infused i.v. just before the inulin priming dose. Inulin sustaining infusions were usually given in 128 mm NaCl-1.5% urea at a rate of 5 ml/min in order to insure moderate diuresis. Preliminary studies showed that mild urea diuresis did not affect P excretion, in confirmation of other reports (4, 5) . Sustaining infusions were given for at least 80 min before control urine collections were started. Urine was collected under paraffin oil through an indwelling catheter, and the 10-min clearance periods were terminated by bladder compression, usually without water or air washout. The completeness of urine collections was confirmed by the very close values of urine flow (V) and inulin clearance (CIn) in consecutive paired periods, and the data presented in the figures are the average values for each such pair. Heparinized blood specimens were obtained from indwelling arterial cannulas at the midpoint of each period; 1 blood pH was measured in specimens collected in oiled syringes usually between consecutive periods. 7 of the dogs received 3-5 g of ammonium chloride orally 18 hr before the experiment After two to three control urine collections were obtained, six dogs were given acetazolamide i.v. (three of them pretreated with ammonium chloride), and seven dogs were given Na-HCO8 i.v. (four of them pretreated with ammonium chloride). NaHCGO was usually given at a rate of 3 mEq/ min for about 10 min, followed by 0.5-0.6 mEq/min; in several studies, no loading dose was given, and the Na-'Venous blood was used in two of the alkalinization experiments and in all of those shown in Table IV. The Journal of Clinical Investigation Volume 47 1968 HCO3 sustaining infusion was larger (Table I) . Acetazolamide was administered in a single dose of 3-5 mg/ kg, sometimes followed by a sustaining infusion of 100-167 ,ug/kg per min; it was also given in seven other studies during NaHCO3 infusion. Clearance periods during bicarbonate infusions were begun an average of 24 min after the preceding control period; after acetazolamide administration, they were started an average of 7 min after the preceding urine collection. Despite these relatively short intervals, the consecutive paired experimental periods matched very closely with respect to V, CIN, and urinary pH. In five experiments the control periods were obtained during the infusion of 0.25-0.4 mEq of NaHCO3 per min, and in one experiment they were obtained during urea-NaCl infusion, after which 50 mmoles of NH4Cl (0.5 mole/liter) was instilled into the dogs' stomachs. After the urine had become acid (85-150 min later), clearance periods were again obtained. Four of these dogs were then given NaHCOs again after these intermediate urinary acidification periods.
The effect of infusing more NaCl, or Na2SO4, was studied in 10 experiments. In five, the control observations made during the infusion of 128 mm NaCl 2 at 5 ml/min were followed by the infusion of 144 mm NaCl at 10 ml/ min. In five others the control observations were followed by priming and sustaining infusions of either NaCl or Na2SO4 which yielded somewhat higher rates of Na' administration than those used in the usual NaHCO3 experiments. The priming infusions delivered 3 mEq of Na' per min for 10 min and the sustaining infusions either 1.13 mEq (as NaCl) or 0.75 mEq (as Na2SO4) per min.
Analytical. The concentration of inorganic P in plasma and urine was estimated by the method of Taussky and Shorr (6) . Inulin was estimated by the method of Higashi and Peters (7) adapted for the Auto- 2 Urea was included in all of these infusions at a concentration calculated to deliver 75 mg/min. The filtered load of P (Fp) was taken as CIn X plasma P and tubular reabsorption of P as Fp -urinary P excretion (UPV). Corrections were not made for the slight binding of P to plasma proteins (8) , for the Donnan effect, or for plasma water concentration, the resultant error presumably being small and consistent in these experiments which involved small changes of blood pH. The average urine pH for each pair of consecutive clearance periods was calculated by converting the individual pH values to H' concentrations, averaging them, and reconverting the averages to pH values. Urinary OH-concentration was calculated from the formula OH-= 10-1 X antilog pH. In making these calculations, H+ concentration was assumed to be equal to H+ activity.
RESULTS
The changes of blood pH averaged only +0.10 ± 0.02 (1 SD) during NaHCO8 infusion, -0.01 ± 0.04 after acetazolamide given during NaCl infusion, and -0.04 + 0.04 after acetazolamide given during NaHCO3 infusion. Plasma P changed relatively little from control values during the experimental periods, averaging -1 % during NaHCO5 infusion and -4% after acetazolamide administration.
The control urinary pH values were between 6.30 and 7.12 during urea-NaCl diuresis. The changes induced ranged from +0.32 to +1.29 pH 3Technicon Instrument Corp., Chauncey, N. Y. Urinary acidification was induced in six experiments by the intragastric instillation of NH4Cl after the control periods had been obtained (Fig.   3 ). Cp/Csn and UpV decreased remarkably when the urine became acid even though Fp actually increased in the first four studies shown. In the last four experiments the dogs were then given NaHCO8 again to reestablish urinary alkalinization, and P excretion thereupon increased to about the original control levels (see representative protocol in Table III ).
The effect of infusing either more saline, or Na2SO4, was examined in order to learn whether Start sustaining infusion of inulin, 5 mg/ml, with 15 mg/ml urea in 128 mM NaCl at 5 ml/min.
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Change sustaining infusion to include 67 mm NaHCO,3 (333 j&moles NaHCO3 per min). Change sustaining infusion to inulin, 5 mg/ml, with 15 mg/ml urea in 600 mM NaHCO3 at 5 ml/min.
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Change sustaining infusion to inulin, 5 mg/ml, with 15 mg/ml urea in 128 mM NaCl-100 mM NaHCO3 at 5 ml/min (500 pmoles NaHCOa per min). the phosphaturic effects of NaHCO. and aceta-Na2SO4, slightly hypertonic NaCl, nor doubling zolamide might be related to either decreased the rate of isotonic NaCl administration had any tubular reabsorption of sodium or perhaps expan-effect on urinary P excretion in 9 of the 10 dogs sion of extracellular fluid volume. Neither infusing (Tables IV and V) regardless of whether natri- However, plasma P tended to decrease during NaHCOQ administration, and glomerular filtration rate (GFR) usually decreased after the administration of acetazolamide. Accordingly, in order to maintain the filtered load of P at a high level, it was necessary for us to increase the rate of P infusion before administering NaHCO3 or acetazolamide, and this increase was often accompanied by an increase of the P filtered load. Therefore, the cause of the decreased TmP observed in those experiments is uncertain because P infusion causes hypocalcemia (10) which evokes increased parathormone secretion (3). Inasmuch as this itself can cause a decrease in the tubular reabsorption of P ( 11), it is difficult to analyze the effects of other concurrent experimental maneuvers on urinary P excretion when exogenous phosphate is infused.
Attempts to evaluate the influence of NaHCO3 and acetazolamide on P excretion in the absence of P loading did pose other problems, however. These were that (a) major changes of blood pH may cause large changes of plasma P and GFR, and hence of Fp, and (b) there are diurnal variations of urinary P excretion. We found in preliminary experiments that moderate systemic acidosis induced by the infusion of HCl at the modest rate of 9-10 mEq/hr often caused GFR to decrease; when NaHCO3 was infused later, GFR increased and plasma P often decreased sharply.5
Therefore, in order to minimize alterations of blood pH and to maintain both GFR and plasma P stable, we deliberately did not aim to achieve intense aciduria during control periods. We have excluded from this report experiments in which the plasma P concentration was not very stable throughout any given experiment, although the results in those experiments were entirely consistent with the findings reported here, We dealt with the problem of diurnal variation of P excretion in two ways. In the experiments in which control urines were acid, the subsequent collections of alkaline urine were obtained after so little delay that diurnal variation was obviously not a significant factor in the increased phosphaturia. Secondly, when the experimental procedure was reversed so that the control urines were alkaline, P excretion was nevertheless also higher than in the later collections of acid urine (Fig. 3) .
Some other investigators who found that NaHCO3 infusion caused increased urinary P excretion ascribed this occurrence to the systemic metabolic alkalosis (12, 13) . It is possible that systemic alkalosis, by decreasing the plasma concentration of ionized calcium, might evoke increased parathormone secretion and in turn decreased tubular reabsorption of phosphate. However, we found that acetazolamide, which does not cause systemic alkalosis, also enhanced phosphaturia (Table II, Fig. 2, and references 2 and 14) . While it is possible that the explanations for the phosphaturic effects of acetazolamide and of NaHCO3 are different, it does seem reasonable to seek a unifying explanation. In this regard the effect of respiratory alkalosis on P excretion was naturally also of interest, but it was not possible to study this effect because both brisk hyperventilation and the administration of tris-(hydroxymethyl)aminomethane (THAM) were accompaned by major decreases of Fp secondary to decreases in both plasma P and GFR. 5 Renal tubular secretion of P has been demonstrated in certain fish (15) , in amphibia (16), and in the chicken (17) , but its existence in mammals is unproven (18, 19) , although it has been suggested by some experiments (20) . If renal tubular secretion of P does occur in dogs, it is possible that the phosphaturia observed in our studies was the consequence of enhanced tubular secretion of P. If phosphate is not secreted by the renal tubules in dogs, our findings are explained by decreased tubular reabsorption of P.6
The mechanism of the phosphaturic effect of NaHCO3 and acetazolamide has not been elucidated by the present studies. Assuming that they depressed tubular reabsorption of P through a common mechanism, one can consider four possible explanations. The phosphaturia may have been related to decreased tubular reabsorption of bicarbonate or sodium or to the urinary or intracellular pH changes induced by NaHCO3 and acetazolamide. Malvin However, they do suggest that the major explanation for NaHCO3-induced phosphaturia in our experiments must be sought elsewhere.
In this light, another possible explanation for our findings is that the mechanisms for the renal tubular reabsorption of H2PO4-and HPOJ are different, as was suggested by Carrasquer and Brodsky (24) . If, for example, the divalent ion HPO4= was less readily reabsorbed by the renal tubules than the monovalent form H2PO4-, the predominance of the divalent anion in alkaline urine (pK ,..8 for H2P4-=HPO4=) would account for decreased reabsorption of total inorganic P from alkaline urine. Alkalinization of proximal tubule fluid during bicarbonate infusion (25) clearly favors a shift of eq4ilibrium from H2PO4-to HP04=. However, Rector, Carter, and Seldin found that carbonic anhydrase inhibition in rats, despite the decreased reabsorption of bicarbonate, caused proximal tubule fluid to become more acid, ostensibly because the catalytic dehydration of H2CO3 was delayed under those circumstances (25) . If this also occurs in dogs, the phosphaturic effect of acetazolamide could not be explained by a shift from H2PO4-to HP04= in proximal tubule fluid. The pH of distal tubule fluid, which presumably does increase during carbonic anhydrase inhibition, may conceivably influence P reabsorption at that site. However, the data from nephron micropuncture studies in rats suggest that most of the reabsorption of P takes place in the proximal tubule (19) . If this is also true in dogs, the small fraction of filtered P that reaches the distal tubule would not be sufficient to account for the increments in Cp/C1n observed in some of our experiments.
It is possible that changes of intracellular rather than of luminal pH in the proximal tubule might account for our findings. One interpretation of the role of carbonic anhydrase in acid-secreting cells is that this enzyme facilitates the cellular generation of carbonic acid, which can then buffer the excess of hydroxyl ions that remains after extrusion of H+ from the cells (26) . In this view, the effect of carbonic anhydrase is to minimize the alkalinity of Hf-secreting cells. Accordingly, inhibition of the enzyme (as by acetazolamide) during H+ secretion would cause cell pH to rise (27) , and it is likely that cell pH also increases during NaHCO3 infusion. Thus, the common factor might be an intracellular shift towards HPOJ, which then impedes the further reabsorptive transport of P across the tubular epithelium.
While the present experiments indicate that acute urinary alkalinization is accompanied by increased P excretion in dogs, as has also recently been reported by Puschett and Goldberg in humans (28) , further studies are needed to assess the effect of longer sustained changes of urinary pH. Nadell administered acetazolamide for several days to humans and found some increase of urinary P excretion, particularly during the 1st day when the urine was most alkaline (29) . On the other hand, Martin and Jones reported that mean urinary P excretion decreased slightly in six subjects who ingested 95 mEq of NaHCO3 daily for 5 days (30), but their subjects' dietary P intakes were not rigidly controlled throughout. Sartorius, Roemmelt, and Pitts reported that urinary P excretion increased when NH4Cl was administered for several days to humans (31) . However, the increased phosphaturia lagged behind urinary acidification, which implies that this was a compensatory phenomenon rather than a primary effect of urinary acidification.
If it should be found that increased phosphaturia is sustained during chronic urinary alkalinization, this may be a factor in the pathogenesis of certain disorders associated with increased urinary P excretion. Although some authors have reported that P excretion was usually normal in patients with urinary tract calcium phosphate calculi (32) , in other series P excretion has been found to be increased in as many as 20% of patients (33) . It is therefore possible that increased phosphaturia may be important in the genesis of some calculi.
The relationship between basal urinary pH, renal acidifying capacity, and urinary P excretion in such patients should be studied. Increased urinary phosphate excretion also occurs in many patients with renal tubular acidosis. The customary explanation is that this increase is secondary to bone dissolution, which is a consequence of hypercalciuria, acidosis, and (or) secondary hyperparathyroidism (34) . Although these may be the major factors, the urinary alkalinity in patients with renal tubular acidosis may also play a role in the pathogenesis of their hyperphosphaturia and renal calcium deposition.
